- Latest available (Revised)
- Original (As adopted by EU)
Commission Implementing Decision (EU) 2016/1116Show full title
Commission Implementing Decision (EU) 2016/1116 of 7 July 2016 amending Implementing Decisions (EU) 2015/1500 and (EU) 2015/2055 on protective measures and vaccination against lumpy skin disease in Greece (notified under document C(2016) 4157) (Only the Greek text is authentic) (Text with EEA relevance)
You are here:
- Decisions originating from the EU
- 2016 No. 1116
- Whole Decision
- Previous
- Next
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Commission Implementing Decision (EU) 2016/1116
Changes to legislation:
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Changes and effects yet to be applied to :
- Decision implicit repeal by EUDN 2016/2008 Decision
Commission Implementing Decision (EU) 2016/1116
of 7 July 2016
amending Implementing Decisions (EU) 2015/1500 and (EU) 2015/2055 on protective measures and vaccination against lumpy skin disease in Greece
(notified under document C(2016) 4157)
(Only the Greek text is authentic)
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Directive 89/662/EEC of 11 December 1989 concerning veterinary checks in intra-Community trade with a view to the completion of the internal market(1), and in particular Article 9(4) thereof,
Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animals and products with a view to the completion of the internal market(2), and in particular Article 10(4) thereof,
Having regard to Council Directive 92/119/EEC of 17 December 1992 introducing general Community measures for the control of certain animal diseases and specific measures relating to swine vesicular disease(3), and in particular Article 19(1)(a), (3)(a) and (6) thereof,
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down the animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption(4), and in particular Article 4(3) thereof,
Whereas:
(1) Directive 92/119/EEC lays down general control measures to be applied in the event of an outbreak of certain animal diseases, including lumpy skin disease (LSD). These control measures include the establishment of protection and surveillance zones around the infected holding, and they also provide for emergency vaccination in the case of an outbreak of LSD as a supplement to other control measures.
(2) Commission Implementing Decision (EU) 2015/1500(5) lays down certain protective animal health control measures in relation to the confirmation of LSD in Greece in 2015. Those measures include the establishment of a restricted zone which is described in the Annex to that Implementing Decision, and which includes the area where LSD was confirmed and the protection and surveillance zones established by Greece in accordance with Directive 92/119/EEC.
(3) Following the evolution of the epidemiological situation in Greece, the Commission adopted Commission Implementing Decision (EU) 2015/2055(6). That Implementing Decision provides that Greece may carry out emergency vaccination of bovine animals kept on holdings in the vaccination zone as set out in Annex I to that Implementing Decision. Implementing Decision (EU) 2015/2055 also amended certain provisions of Implementing Decision (EU) 2015/1500, including the extension of the restricted zone in order to include not only the regional unit of Evros, but also the regional units of Rodopi, Xanthi, Kavala and Limnos.
(4) Implementing Decisions (EU) 2015/1500 and (EU) 2015/2055 were subsequently amended by Commission Implementing Decision (EU) 2015/2311(7), in order to extend the restricted zone set out in the Annex to Implementing Decision (EU) 2015/1500, as well as the vaccination zone as set out in Annex I to Implementing Decision (EU) 2015/2055, following confirmation of additional outbreaks of LSD in the regional unit of Chalkidiki and the receipt of notification from Greece of its intention to carry out vaccination against LSD in the regional units of Chalkidiki, Thessaloniki, Kilkis, Drama and Serres.
(5) Since 6 April 2016, Greece has reported new outbreaks of LSD in the restricted zone as set out in the Annex to Implementing Decision (EU) 2015/1500 and the vaccination zone as set out in Annex I to Implementing Decision (EU) 2015/2055. There have also been reported outbreaks of LSD in Bulgaria since 13 April 2016, and the former Yugoslav Republic of Macedonia since 21 April 2016.
(6) On 9 May 2016, Greece notified the Commission of its intention to carry out vaccination in the regional units of Pella, Pieria and Imathia as a precautionary measure due to the development of the epidemiological situation as regards LSD. On 1 June 2016 Greece notified again the Commission on their intention to carry out vaccination in the regional units of Florina, Kastoria and Kozani as an additional precautionary measure due to the development of the epidemiological situation as regards LSD. Such vaccination requires an enlargement of the restricted zone set out in the Annex to Implementing Decision (EU) 2015/1500, as well as the vaccination zone as set out in Annex I to Implementing Decision (EU) 2015/2055. Implementing Decisions (EU) 2015/1500 and (EU) 2015/2055 should therefore be amended accordingly.
(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
Article 1U.K.
The Annex to Implementing Decision (EU) 2015/1500 is replaced by the text set out in Annex I to this Decision
Article 2U.K.
Annex I to Implemening Decision (EU) 2015/2055 is replaced by the text set out in Annex II to this Decision
Article 3U.K.
This Decision is addressed to the Hellenic Republic.
Done at Brussels, 7 July 2016
For the Commission
Vytenis Andriukaitis
Member of the Commission
ANNEX IU.K.
The Annex to Implementing Decision (EU) 2015/1500 is replaced by the following:
“ANNEX RESTRICTED ZONES REFERRED TO IN ARTICLE 2(b)
The following regional units in Greece:
Regional unit of Evros
Regional unit of Rodopi
Regional unit of Xanthi
Regional unit of Kavala
Regional unit of Drama
Regional unit of Serres
Regional unit of Chalkidiki
Regional unit of Thessaloniki
Regional unit of Kilkis
Regional unit of Pieria
Regional unit of Imathia
Regional unit of Pella
Regional unit of Florina
Regional unit of Kastoria
Regional unit of Kozani
Regional unit of Limnos.”
ANNEX IIU.K.
Annex I to Implemening Decision (EU) 2015/2055 is replaced by the following:
“ANNEX I
The following regional units in Greece:
Regional unit of Evros
Regional unit of Rodopi
Regional unit of Xanthi
Regional unit of Kavala
Regional unit of Drama
Regional unit of Serres
Regional unit of Chalkidiki
Regional unit of Thessaloniki
Regional unit of Kilkis
Regional unit of Pieria
Regional unit of Imathia
Regional unit of Pella
Regional unit of Florina
Regional unit of Kastoria
Regional unit of Kozani
Regional unit of Limnos.”
(5)
Commission Implementing Decision (EU) 2015/1500 of 7 September 2015 concerning certain protective measures against lumpy skin disease in Greece and repealing Implementing Decision (EU) 2015/1423 (OJ L 234, 8.9.2015, p. 19).
(6)
Commission Implementing Decision (EU) 2015/2055 of 10 November 2015 laying down the conditions for setting out the programme for emergency vaccination of bovine animals against lumpy skin disease in Greece and amending Implementing Decision (EU) 2015/1500 (OJ L 300, 17.11.2015, p. 31).
(7)
Commission Implementing Decision (EU) 2015/2311 of 9 December 2015 amending Implementing Decisions (EU) 2015/1500 and (EU) 2015/2055 on protective measures against lumpy skin disease in Greece (OJ L 326, 11.12.2015, p. 65).
Options/Help
Print Options
PrintThe Whole Decision
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.